期刊文献+

非酒精性脂肪肝肝细胞肝癌(HCC)的MR诊断 被引量:1

Magnetic resonance diagnosis on non-alcoholic fatty liver hcpatocellular carcinoma
下载PDF
导出
摘要 目的观察非酒精性脂肪肝肝细胞肝癌(HCC)的MR诊断表现及检出率。方法对2009年10月至2010年5月在我院确诊为非酒精性脂肪肝肝细胞肝癌的67例患者进行MR检测。结果MR结果显示,67例患者均出现长T1、长T2信号,且对其进行MRI测定后发现其动脉期出现明显强化,而门脉期和平衡期的强化程度则明显下降。部分患者显示出强化的环形肿瘤包膜。MR对于HCC的诊断率为100%。结论非酒精性脂肪肝肝细胞肝癌(HCC)的MR诊断检出率高。 Objective To observe non-alcoholic fatty liver hepatocellular carcinoma (HCC) magnetic reso- nance (MR) diagnostic performance, and detection rate. Method From October 2009 to May 2010 in our hospital, 67 patients were diagnosed with non-alcoholic fatty liver disease in patients with HCC detected by MR. Results According to the results of MR, all 67 patients showed long T1 and long T2 signals, and after MRI determination the arterial phase appeared obviously strengthened, while the portal phase and equilibrium phase enhancement degree decreased. Some patients showed a reinforced annular tumor capsule. According to the results, the diagnosis rate of MR to HCC was 100%. Conclusion MR diagnosis has the high detection rate in non-alcoholic fatty liver HCC.
出处 《国际医药卫生导报》 2012年第14期2074-2075,共2页 International Medicine and Health Guidance News
关键词 非酒精性脂肪肝肝细胞肝癌 MR诊断 Non-alcoholic fatty liver Hepatocellular carcinoma (HCC) Magnetic resonance diagnosis
  • 相关文献

参考文献6

二级参考文献30

共引文献3375

同被引文献14

  • 1Hui E,Xu A,Bo Yang H,et al. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines [J]. J Diabetes Investig,2013,4(5) :413-425.
  • 2Donqiobanni P, Anstee QM, Valenti L. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and re sponse to treatment[J]. Curr Pharm Des, 2013, 19(29): 5219- 5238.
  • 3Paradis V, Zalinski S, Chelbi E, et al. Hepatoeellular carcinomas in patients with metabolic syndrome often develop without sig- nificant liver fibrosis, a pathological analysis [J]. H epatology, 2009,49(3) :851-859.
  • 4Gedaly R,Angulo P,Hundley J,et al. PKI-587 and sorafenib tar geting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways syn- erqistically inhibit HCC cell proliferation[J]. 2012,176(2) : 542- 548.
  • 5Zeng T,Zhang CL,Song FY,et al. PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice[J], Tox icology, 2012,296(1-3) : 56-66.
  • 6Sui G,Ma X,Liu S,et al. Study of the correlation between H-ras mutation and primary hepatocellular carcinoma[J]. Oncol Lett, 2012,4(4):779 782.
  • 7Wang AG, Moon HB, Lee MR, et al. Gender-dependent hepatic alterations in H-rasl2V transgenic mice[J]. J Hepato], 2005,43 (5) :836-44.
  • 8Frith CH ,Ward JM. A morphologic classification of proliferative and neoplastic hepatic lesions in mice[J]. J Environ Pathol Toxi col, 1979,3(1-2) : 329-351.
  • 9Li L,Wang C, Calvisi DF, et al. SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice[J]. PloS One,2013,8(9) 1 12.
  • 10Liu L,Xie Y, Lou L. PI3K is required for insulin-stimulated but not EGF-stimulated ERK1/2 activation[J]. Eur J Cell Boil, 2006,85(5) :367-374.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部